253 related articles for article (PubMed ID: 33563177)
41. Stem cell programs in cancer initiation, progression, and therapy resistance.
Huang T; Song X; Xu D; Tiek D; Goenka A; Wu B; Sastry N; Hu B; Cheng SY
Theranostics; 2020; 10(19):8721-8743. PubMed ID: 32754274
[TBL] [Abstract][Full Text] [Related]
42. Developmental signaling pathways regulating mammary stem cells and contributing to the etiology of triple-negative breast cancer.
Rangel MC; Bertolette D; Castro NP; Klauzinska M; Cuttitta F; Salomon DS
Breast Cancer Res Treat; 2016 Apr; 156(2):211-26. PubMed ID: 26968398
[TBL] [Abstract][Full Text] [Related]
43. Novel Therapeutics Against Breast Cancer Stem Cells by Targeting Surface Markers and Signaling Pathways.
Das PK; Rakib MA; Khanam JA; Pillai S; Islam F
Curr Stem Cell Res Ther; 2019; 14(8):669-682. PubMed ID: 31808385
[TBL] [Abstract][Full Text] [Related]
44. Role, molecular mechanism and the potential target of breast cancer stem cells in breast cancer development.
Zhang T; Zhou H; Wang K; Wang X; Wang M; Zhao W; Xi X; Li Y; Cai M; Zhao W; Xu Y; Shao R
Biomed Pharmacother; 2022 Mar; 147():112616. PubMed ID: 35008001
[TBL] [Abstract][Full Text] [Related]
45. The roles of ncRNAs and histone-modifiers in regulating breast cancer stem cells.
Zhao Z; Li S; Song E; Liu S
Protein Cell; 2016 Feb; 7(2):89-99. PubMed ID: 26349457
[TBL] [Abstract][Full Text] [Related]
46. Mechanisms of cancer stem cell therapy.
Akbar Samadani A; Keymoradzdeh A; Shams S; Soleymanpour A; Elham Norollahi S; Vahidi S; Rashidy-Pour A; Ashraf A; Mirzajani E; Khanaki K; Rahbar Taramsari M; Samimian S; Najafzadeh A
Clin Chim Acta; 2020 Nov; 510():581-592. PubMed ID: 32791136
[TBL] [Abstract][Full Text] [Related]
47. Nectin-4 is a breast cancer stem cell marker that induces WNT/β-catenin signaling via Pi3k/Akt axis.
Siddharth S; Goutam K; Das S; Nayak A; Nayak D; Sethy C; Wyatt MD; Kundu CN
Int J Biochem Cell Biol; 2017 Aug; 89():85-94. PubMed ID: 28600142
[TBL] [Abstract][Full Text] [Related]
48. Blockade of Wnt/β-catenin signaling suppresses breast cancer metastasis by inhibiting CSC-like phenotype.
Jang GB; Kim JY; Cho SD; Park KS; Jung JY; Lee HY; Hong IS; Nam JS
Sci Rep; 2015 Jul; 5():12465. PubMed ID: 26202299
[TBL] [Abstract][Full Text] [Related]
49. Long Noncoding RNA
Chen X; Xie R; Gu P; Huang M; Han J; Dong W; Xie W; Wang B; He W; Zhong G; Chen Z; Huang J; Lin T
Clin Cancer Res; 2019 Feb; 25(4):1389-1403. PubMed ID: 30397178
[TBL] [Abstract][Full Text] [Related]
50. Non-coding RNAs Functioning in Colorectal Cancer Stem Cells.
Fanale D; Barraco N; Listì A; Bazan V; Russo A
Adv Exp Med Biol; 2016; 937():93-108. PubMed ID: 27573896
[TBL] [Abstract][Full Text] [Related]
51. Cancer stem cell in breast cancer therapeutic resistance.
Bai X; Ni J; Beretov J; Graham P; Li Y
Cancer Treat Rev; 2018 Sep; 69():152-163. PubMed ID: 30029203
[TBL] [Abstract][Full Text] [Related]
52. The epigenetic landscape of mammary gland development and functional differentiation.
Rijnkels M; Kabotyanski E; Montazer-Torbati MB; Hue Beauvais C; Vassetzky Y; Rosen JM; Devinoy E
J Mammary Gland Biol Neoplasia; 2010 Mar; 15(1):85-100. PubMed ID: 20157770
[TBL] [Abstract][Full Text] [Related]
53. Epigenetic regulation of cancer stem cells in liver cancer: current concepts and clinical implications.
Marquardt JU; Factor VM; Thorgeirsson SS
J Hepatol; 2010 Sep; 53(3):568-77. PubMed ID: 20646772
[TBL] [Abstract][Full Text] [Related]
54. Breast cancer epigenetics: normal human mammary epithelial cells as a model system.
Hinshelwood RA; Clark SJ
J Mol Med (Berl); 2008 Dec; 86(12):1315-28. PubMed ID: 18716754
[TBL] [Abstract][Full Text] [Related]
55. HOXC8 regulates self-renewal, differentiation and transformation of breast cancer stem cells.
Shah M; Cardenas R; Wang B; Persson J; Mongan NP; Grabowska A; Allegrucci C
Mol Cancer; 2017 Feb; 16(1):38. PubMed ID: 28202042
[TBL] [Abstract][Full Text] [Related]
56. Overexpression of OCT4 induced by modulation of histone marks plays crucial role in breast cancer progression.
Kar S; Patra SK
Gene; 2018 Feb; 643():35-45. PubMed ID: 29203199
[TBL] [Abstract][Full Text] [Related]
57. Differentiation of breast cancer stem cells by knockdown of CD44: promising differentiation therapy.
Pham PV; Phan NL; Nguyen NT; Truong NH; Duong TT; Le DV; Truong KD; Phan NK
J Transl Med; 2011 Dec; 9():209. PubMed ID: 22152097
[TBL] [Abstract][Full Text] [Related]
58. Fascin Is Critical for the Maintenance of Breast Cancer Stem Cell Pool Predominantly via the Activation of the Notch Self-Renewal Pathway.
Barnawi R; Al-Khaldi S; Majed Sleiman G; Sarkar A; Al-Dhfyan A; Al-Mohanna F; Ghebeh H; Al-Alwan M
Stem Cells; 2016 Dec; 34(12):2799-2813. PubMed ID: 27502039
[TBL] [Abstract][Full Text] [Related]
59. Mechanistic Pathways of Malignancy in Breast Cancer Stem Cells.
Yousefnia S; Seyed Forootan F; Seyed Forootan S; Nasr Esfahani MH; Gure AO; Ghaedi K
Front Oncol; 2020; 10():452. PubMed ID: 32426267
[TBL] [Abstract][Full Text] [Related]
60. Analysis of microRNA expression in canine mammary cancer stem-like cells indicates epigenetic regulation of transforming growth factor-beta signaling.
Rybicka A; Mucha J; Majchrzak K; Taciak B; Hellmen E; Motyl T; Krol M
J Physiol Pharmacol; 2015 Feb; 66(1):29-37. PubMed ID: 25716962
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
